Zevra Therapeutics (ZVRA) Long-Term Investments: 2016-2025
Historic Long-Term Investments for Zevra Therapeutics (ZVRA) over the last 2 years, with Sep 2025 value amounting to $30.9 million.
- Zevra Therapeutics' Long-Term Investments rose 405.57% to $30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year increase of 405.57%. This contributed to the annual value of $6.0 million for FY2024, which is N/A change from last year.
- Latest data reveals that Zevra Therapeutics reported Long-Term Investments of $30.9 million as of Q3 2025, which was up 104.55% from $15.1 million recorded in Q2 2025.
- Zevra Therapeutics' Long-Term Investments' 5-year high stood at $33.5 million during Q2 2022, with a 5-year trough of $6.0 million in Q4 2024.
- In the last 2 years, Zevra Therapeutics' Long-Term Investments had a median value of $6.1 million in 2024 and averaged $12.8 million.
- Data for Zevra Therapeutics' Long-Term Investments shows a peak YoY soared of 405.57% (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Zevra Therapeutics' Long-Term Investments stood at $14.9 million in 2021, then soared by 33.94% to $20.0 million in 2022, then reached $6.0 million in 2024, then skyrocketed by 405.57% to $30.9 million in 2025.
- Its Long-Term Investments stands at $30.9 million for Q3 2025, versus $15.1 million for Q2 2025 and $6.1 million for Q1 2025.